# ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial

> **NCT00941252** · PHASE2,PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 60 (estimated)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DRUG:** Topical imiquimod therapy

## Key facts

- **NCT ID:** NCT00941252
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941252, "ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00941252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*